Effects of solubilization and vanadate/glutathione complex on inhibitor potencies against eosinophil cyclic AMP-specific phosphodiesterase

FEBS Lett. 1992 May 11;302(2):181-4. doi: 10.1016/0014-5793(92)80435-j.

Abstract

Treatment of membranes from guinea-pig peritoneal eosinophils with deoxycholate and NaCl solubilized greater than 95% of the particulate cyclic AMP-specific phosphodiesterase (PDE IV). Solubilized PDE IV was at least 10 times more potently inhibited by selective PDE IV inhibitors (e.g. rolipram, denbufylline) than bound enzyme. Vanadate/glutathione complex (V/GSH) activated membrane-bound PDE IV and also increased potencies of these same inhibitors by at least 10-fold. Neither solubilization nor V/GSH markedly influenced the inhibitory activities of non-selective inhibitors (e.g. trequinsin, dipyridamole). Inhibitor effects on solubilized PDE IV and cyclic AMP accumulation in intact cells were strongly correlated. These results suggest a biologically important site on eosinophil PDE IV which is concealed or partially concealed in freshly prepared membranes and is exposed by solubilization or V/GSH.

MeSH terms

  • 3',5'-Cyclic-AMP Phosphodiesterases / antagonists & inhibitors*
  • 3',5'-Cyclic-AMP Phosphodiesterases / metabolism
  • 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone / pharmacology
  • Animals
  • Cell Membrane / enzymology
  • Enzyme Activation
  • Eosinophils / enzymology*
  • Glutathione / metabolism*
  • Glutathione / pharmacology
  • Guinea Pigs
  • Pyrrolidinones / pharmacology
  • Rolipram
  • Solubility
  • Vanadates / metabolism*
  • Vanadates / pharmacology
  • Xanthines / pharmacology

Substances

  • Pyrrolidinones
  • Xanthines
  • denbufylline
  • 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone
  • Vanadates
  • 3',5'-Cyclic-AMP Phosphodiesterases
  • Glutathione
  • Rolipram